Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111K Sell
77,552
-38,129
-33% -$68.8K ﹤0.01% 3584
2026
Q1
$209K Buy
+115,681
New +$211K ﹤0.01% 3173
2025
Q2
Sell
-12,104
Closed -$6K 3166
2025
Q1
$6K Sell
12,104
-11,823
-49% -$11.1K ﹤0.01% 2393
2024
Q4
$30K Buy
+23,927
New +$27.6K ﹤0.01% 2161
2024
Q2
Sell
-19,741
Closed -$24K 2698
2024
Q1
$24K Buy
+19,741
New +$28.6K ﹤0.01% 1995
2021
Q3
Sell
-2,442
Closed -$734K 3543
2021
Q2
$734K Buy
2,442
+59
+2% +$17.7K 0.01% 1442
2021
Q1
$714K Buy
+2,383
New +$807K 0.01% 1514

Other funds holding LIDR

HRT Financial's LIDR Position: Q2 2026 in Review

HRT Financial reduced its AEye (LIDR) stake by 33% in Q2 2026, selling an estimated $68.8K and leaving 77,552 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #3584.

HRT Financial first reported a position in LIDR in Q1 2021 and has held it in 7 quarters since. The position peaked at $734K in Q2 2021. 51 funds tracked by Wall St. Rank hold LIDR as of Q2 2026.

  • HRT Financial held 77,552 shares of AEye worth $111K as of Q2 2026.
  • HRT Financial sold 38,129 AEye shares in Q2 2026, an estimated $68.8K.
  • AEye made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3584 holding.
  • HRT Financial first reported a position in AEye in Q1 2021 and has held it in 7 quarters since.
  • HRT Financial's AEye position peaked at $734K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held AEye as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.